Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Schölmerich J[au]:

Preface. Schölmerich J et al. Dig Dis. (2016)

Extraintestinal manifestations and complications in IBD. Ott C et al. Nat Rev Gastroenterol Hepatol. (2013)

A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn's Disease. Schölmerich J et al. J Crohns Colitis. (2017)

Search results

Items: 1 to 50 of 889

1.

Approaches to Integrating Biomarkers into Clinical Trials and Care Pathways as Targets for Treatment of Inflammatory Bowel Diseases.

Dulai PS, Peyrin-Biroulet L, Danese S, Sands BE, Dignass A, Turner D, Mantzaris G, Schölmerich J, Mary JY, Reinisch W, Sandborn WJ.

Gastroenterology. 2019 Jun 19. pii: S0016-5085(19)41020-2. doi: 10.1053/j.gastro.2019.06.018. [Epub ahead of print]

PMID:
31228441
2.

Influence of NOD2 Variants on Trichuris suis ova Treatment Outcome in Crohn's Disease.

Jaeger SU, Schaeffeler E, Winter S, Tremmel R, Schölmerich J, Malek N, Stange EF, Schwab M, Wehkamp J.

Front Pharmacol. 2018 Jul 16;9:764. doi: 10.3389/fphar.2018.00764. eCollection 2018.

3.

A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn's Disease.

Schölmerich J, Fellermann K, Seibold FW, Rogler G, Langhorst J, Howaldt S, Novacek G, Petersen AM, Bachmann O, Matthes H, Hesselbarth N, Teich N, Wehkamp J, Klaus J, Ott C, Dilger K, Greinwald R, Mueller R; International TRUST-2 Study Group.

J Crohns Colitis. 2017 Apr 1;11(4):390-399. doi: 10.1093/ecco-jcc/jjw184.

4.

Preface.

Schölmerich J.

Dig Dis. 2016;34(5):461. doi: 10.1159/000445851. Epub 2016 Jun 22. No abstract available.

PMID:
27333056
5.

Trichuris suis ova, lecithin and other fancy molecules.

Schölmerich J.

Dig Dis. 2014;32 Suppl 1:67-73. doi: 10.1159/000367831. Epub 2014 Dec 17. Review.

PMID:
25531355
6.

Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.

Pariente B, Mary JY, Danese S, Chowers Y, De Cruz P, D'Haens G, Loftus EV Jr, Louis E, Panés J, Schölmerich J, Schreiber S, Vecchi M, Branche J, Bruining D, Fiorino G, Herzog M, Kamm MA, Klein A, Lewin M, Meunier P, Ordas I, Strauch U, Tontini GE, Zagdanski AM, Bonifacio C, Rimola J, Nachury M, Leroy C, Sandborn W, Colombel JF, Cosnes J.

Gastroenterology. 2015 Jan;148(1):52-63.e3. doi: 10.1053/j.gastro.2014.09.015. Epub 2014 Sep 21.

PMID:
25241327
7.

Trichuris suis ova in inflammatory bowel disease.

Schölmerich J.

Dig Dis. 2013;31(3-4):391-5. doi: 10.1159/000354708. Epub 2013 Nov 14. Review.

PMID:
24246995
8.

Extraintestinal manifestations and complications in IBD.

Ott C, Schölmerich J.

Nat Rev Gastroenterol Hepatol. 2013 Oct;10(10):585-95. doi: 10.1038/nrgastro.2013.117. Epub 2013 Jul 9. Review.

PMID:
23835489
9.

[Survey medical intensive care: structure of in-patient care and supply of services in medical intensive care].

Welte T, Lehnert H, Schölmerich J, Buerke M; Task Force Intensivmedizin der Deutschen Gesellschaft für Innere Medizin (DGIM).

Dtsch Med Wochenschr. 2012 Dec;137(49):2596-601. doi: 10.1055/s-0032-1327243. Epub 2012 Nov 6. German. No abstract available.

PMID:
23132216
10.

Combined immunosuppression is more dangerous than monotherapy: what is fact and what is fiction?

Schölmerich J.

Dig Dis. 2012;30(4):404-7. doi: 10.1159/000338140. Epub 2012 Jul 12. Review.

PMID:
22796806
11.

Topical delivery of steroids in inflammatory bowel disease.

Girlich C, Scholmerich J.

Curr Drug Deliv. 2012 Jul;9(4):345-9. Review.

PMID:
22762277
12.

Loss of sensory and noradrenergic innervation in benign colorectal adenomatous polyps--a putative role of semaphorins 3F and 3A.

Graf N, McLean M, Capellino S, Schölmerich J, Murray GI, El-Omar EM, Straub RH.

Neurogastroenterol Motil. 2012 Feb;24(2):120-8, e83. doi: 10.1111/j.1365-2982.2011.01818.x. Epub 2011 Nov 16.

PMID:
22093159
13.

Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis.

Walter R, Wanninger J, Bauer S, Eisinger K, Neumeier M, Weiss TS, Amann T, Hellerbrand C, Schäffler A, Schölmerich J, Buechler C.

Exp Mol Pathol. 2011 Dec;91(3):740-4. doi: 10.1016/j.yexmp.2011.09.006. Epub 2011 Sep 17.

PMID:
21946149
14.

NOD2 gene variants are a risk factor for culture-positive spontaneous bacterial peritonitis and monomicrobial bacterascites in cirrhosis.

Bruns T, Peter J, Reuken PA, Grabe DH, Schuldes SR, Brenmoehl J, Schölmerich J, Wiest R, Stallmach A.

Liver Int. 2012 Feb;32(2):223-30. doi: 10.1111/j.1478-3231.2011.02561.x. Epub 2011 Jun 13.

PMID:
21745302
15.

Necrotizing tuberculosis with duodenal perforation as a primary manifestation of AIDS.

Hartl J, Maier J, Caselitz M, Salzberger B, Wagner S, Zuelke C, Blaas S, Lubnow M, Schölmerich J, Kirchner GI.

Int J Colorectal Dis. 2012 May;27(5):687-8. doi: 10.1007/s00384-011-1277-6. Epub 2011 Jul 9. No abstract available.

PMID:
21744119
16.

DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH.

Gäbele E, Dostert K, Hofmann C, Wiest R, Schölmerich J, Hellerbrand C, Obermeier F.

J Hepatol. 2011 Dec;55(6):1391-9. doi: 10.1016/j.jhep.2011.02.035. Epub 2011 Apr 13.

PMID:
21703208
17.

BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells.

Hausmann M, Leucht K, Ploner C, Kiessling S, Villunger A, Becker H, Hofmann C, Falk W, Krebs M, Kellermeier S, Fried M, Schölmerich J, Obermeier F, Rogler G.

J Biol Chem. 2011 Jul 29;286(30):26533-40. doi: 10.1074/jbc.M111.265322. Epub 2011 Jun 14.

18.

Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center.

Ott C, Girlich C, Klebl F, Plentz A, Iesalnieks I, Schölmerich J, Obermeier F.

Digestion. 2011;84(3):187-92. doi: 10.1159/000324617. Epub 2011 Jun 1.

PMID:
21646782
19.

Causes of bolus impaction in the esophagus.

Kirchner GI, Zuber-Jerger I, Endlicher E, Gelbmann C, Ott C, Ruemmele P, Schölmerich J, Klebl F.

Surg Endosc. 2011 Oct;25(10):3170-4. doi: 10.1007/s00464-011-1681-6. Epub 2011 Apr 13.

PMID:
21487866
20.

Mucosal immunosuppression and epithelial barrier defects are key events in murine psychosocial stress-induced colitis.

Reber SO, Peters S, Slattery DA, Hofmann C, Schölmerich J, Neumann ID, Obermeier F.

Brain Behav Immun. 2011 Aug;25(6):1153-61. doi: 10.1016/j.bbi.2011.03.004. Epub 2011 Mar 21.

PMID:
21397685
21.

RAP-PCR fingerprinting reveals time-dependent expression of matrix-related molecules following stem-cell based TGFβ1-induced chondrocyte development.

Schedel J, Lowin T, Kujat R, Judex M, Schölmerich J, Nerlich M, Müller-Ladner U, Angele P.

Int J Mol Med. 2011 Apr;27(4):519-23. doi: 10.3892/ijmm.2011.608. Epub 2011 Feb 1.

PMID:
21286661
22.

Admission visfatin levels predict pancreatic and peripancreatic necrosis in acute pancreatitis and correlate with clinical severity.

Schäffler A, Hamer OW, Dickopf J, Goetz A, Landfried K, Voelk M, Herfarth H, Kopp A, Buechler C, Schölmerich J, Brünnler T.

Am J Gastroenterol. 2011 May;106(5):957-67. doi: 10.1038/ajg.2010.503. Epub 2011 Jan 18.

PMID:
21245835
23.

Fibrin glue in the endoscopic treatment of fistulae and anastomotic leakages of the gastrointestinal tract.

Lippert E, Klebl FH, Schweller F, Ott C, Gelbmann CM, Schölmerich J, Endlicher E, Kullmann F.

Int J Colorectal Dis. 2011 Mar;26(3):303-11. doi: 10.1007/s00384-010-1104-5. Epub 2010 Dec 29.

PMID:
21190028
24.

Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation.

Kirchner GI, Scherer MN, Obed A, Ruemmele P, Wiest R, Froh M, Loss M, Schlitt HJ, Schölmerich J, Gelbmann CM.

Scand J Gastroenterol. 2011 Apr;46(4):471-8. doi: 10.3109/00365521.2010.537683. Epub 2010 Nov 30.

PMID:
21114429
25.

Type 2 diabetes and lipoprotein metabolism affect LPS-induced cytokine and chemokine release in primary human monocytes.

Bala M, Kopp A, Wurm S, Büchler C, Schölmerich J, Schäffler A.

Exp Clin Endocrinol Diabetes. 2011 Jun;119(6):370-6. doi: 10.1055/s-0030-1268413. Epub 2010 Nov 22.

PMID:
21104588
26.

Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes.

Wanninger J, Neumeier M, Hellerbrand C, Schacherer D, Bauer S, Weiss TS, Huber H, Schäffler A, Aslanidis C, Schölmerich J, Buechler C.

Biochim Biophys Acta. 2011 Oct;1811(10):626-33. doi: 10.1016/j.bbalip.2010.11.001. Epub 2010 Nov 8.

PMID:
21070865
27.

Volcano-like intermittent bleeding activity for seven years from an arterio-enteric fistula on a kidney graft site after pancreas-kidney transplantation: a case report.

Härle P, Schwarz S, Langgartner J, Schölmerich J, Rogler G.

J Med Case Rep. 2010 Nov 8;4:357. doi: 10.1186/1752-1947-4-357.

28.

[69 year-old patient with chronic abdominal pain and anemia in neurofibromatosis].

Schulz M, Schreyer A, Glöckner SC, Schölmerich J, Zuber-Jerger I.

Internist (Berl). 2011 Jan;52(1):81-2, 84-6, 88. doi: 10.1007/s00108-010-2653-y. German.

PMID:
20941477
29.

Evolving concepts in IBD therapy: What should be studied in the future?

Schölmerich J.

Dig Dis. 2010;28(3):472-7. doi: 10.1159/000320404. Epub 2010 Sep 30.

PMID:
20926874
30.

Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia.

Hanses F, Spaeth C, Ehrenstein BP, Linde HJ, Schölmerich J, Salzberger B.

Infection. 2010 Dec;38(6):465-70. doi: 10.1007/s15010-010-0059-3. Epub 2010 Sep 29.

PMID:
20878456
31.

Serum BAFF strongly correlates with PsA activity in male patients only--is there a role for sex hormones?

Pongratz G, Straub RH, Schölmerich J, Fleck M, Härle P.

Clin Exp Rheumatol. 2010 Nov-Dec;28(6):813-9. Epub 2011 Jan 3.

PMID:
20863443
32.

Specific differences in migratory function of myofibroblasts isolated from Crohn's disease fistulae and strictures.

Meier JK, Scharl M, Miller SN, Brenmoehl J, Hausmann M, Kellermeier S, Schölmerich J, Rogler G.

Inflamm Bowel Dis. 2011 Jan;17(1):202-12. doi: 10.1002/ibd.21344.

PMID:
20848526
33.

Glycogen synthase kinase 3-β: a master regulator of toll-like receptor-mediated chronic intestinal inflammation.

Hofmann C, Dunger N, Schölmerich J, Falk W, Obermeier F.

Inflamm Bowel Dis. 2010 Nov;16(11):1850-8. doi: 10.1002/ibd.21294.

PMID:
20848477
34.

Clinical feature and bowel ultrasound in Crohn's disease - does additional information from magnetic resonance imaging affect therapeutic approach and when does extended diagnostic investigation make sense?

Girlich C, Ott C, Strauch U, Schacherer D, Obermeier F, Jung EM, Schölmerich J, Schreyer AG, Klebl F.

Digestion. 2011;83(1-2):18-23. doi: 10.1159/000314590. Epub 2010 Sep 14.

PMID:
20838051
35.

Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics.

Kirovski G, Schacherer D, Wobser H, Huber H, Niessen C, Beer C, Schölmerich J, Hellerbrand C.

Int J Clin Exp Med. 2010 Jul 15;3(3):202-10.

36.

Prostaglandin E2 inhibits migration of colonic lamina propria fibroblasts.

Rieder F, Georgieva M, Schirbel A, Artinger M, Zügner A, Blank M, Brenmoehl J, Schölmerich J, Rogler G.

Inflamm Bowel Dis. 2010 Sep;16(9):1505-13. doi: 10.1002/ibd.21255.

PMID:
20803697
37.

Dietary folic acid activates AMPK and improves insulin resistance and hepatic inflammation in dietary rodent models of the metabolic syndrome.

Buettner R, Bettermann I, Hechtl C, Gäbele E, Hellerbrand C, Schölmerich J, Bollheimer LC.

Horm Metab Res. 2010 Oct;42(11):769-74. doi: 10.1055/s-0030-1263122. Epub 2010 Aug 27.

PMID:
20803414
38.

C1q/TNF-related protein-3 represents a novel and endogenous lipopolysaccharide antagonist of the adipose tissue.

Kopp A, Bala M, Buechler C, Falk W, Gross P, Neumeier M, Schölmerich J, Schäffler A.

Endocrinology. 2010 Nov;151(11):5267-78. doi: 10.1210/en.2010-0571. Epub 2010 Aug 25. Erratum in: Endocrinology. 2013 Apr;154(4):1667.

PMID:
20739398
39.

T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells.

Hofmann C, Dunger N, Grunwald N, Hämmerling GJ, Hoffmann P, Schölmerich J, Falk W, Obermeier F.

Gut. 2010 Oct;59(10):1347-54. doi: 10.1136/gut.2009.193177. Epub 2010 Aug 23.

PMID:
20732920
40.

Cryptococcosis mimicking cutaneous cellulitis in a patient suffering from rheumatoid arthritis: a case report.

Probst C, Pongratz G, Capellino S, Szeimies RM, Schölmerich J, Fleck M, Salzberger B, Ehrenstein B.

BMC Infect Dis. 2010 Aug 11;10:239. doi: 10.1186/1471-2334-10-239.

41.

Admission resistin levels predict peripancreatic necrosis and clinical severity in acute pancreatitis.

Schäffler A, Hamer O, Dickopf J, Goetz A, Landfried K, Voelk M, Herfarth H, Kopp A, Büchler C, Schölmerich J, Brünnler T.

Am J Gastroenterol. 2010 Nov;105(11):2474-84. doi: 10.1038/ajg.2010.278. Epub 2010 Jul 20.

PMID:
20648005
42.

Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis.

Wiest R, Weigert J, Wanninger J, Neumeier M, Bauer S, Schmidhofer S, Farkas S, Scherer MN, Schäffler A, Schölmerich J, Buechler C.

Cytokine. 2011 Feb;53(2):178-83. doi: 10.1016/j.cyto.2010.06.013. Epub 2010 Jul 15.

PMID:
20637651
43.

Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany.

Kirchner G, Kirovski G, Hebestreit A, Schölmerich J, Schlitt HJ, Stoeltzing O, Hellerbrand C.

Int J Clin Exp Med. 2010 Jun 10;3(2):169-79.

44.

Splanchnic sympathectomy prevents translocation and spreading of E coli but not S aureus in liver cirrhosis.

Worlicek M, Knebel K, Linde HJ, Moleda L, Schölmerich J, Straub RH, Wiest R.

Gut. 2010 Aug;59(8):1127-34. doi: 10.1136/gut.2009.185413. Epub 2010 Jun 2.

PMID:
20519743
45.

Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts.

Neumann E, Riepl B, Knedla A, Lefèvre S, Tarner IH, Grifka J, Steinmeyer J, Schölmerich J, Gay S, Müller-Ladner U.

Arthritis Res Ther. 2010;12(3):R83. doi: 10.1186/ar3010. Epub 2010 May 12.

46.

[Case report--the most important element of continuing education].

Schölmerich J.

Med Klin (Munich). 2010 Apr;105(4):225. doi: 10.1007/s00063-010-1051-5. German. No abstract available.

PMID:
20455037
47.

[Internal medicine in a postmodern society. Address at the festive evening event to mark the 116th Congress of the German Society of Internal Medicine on 11 April 2010].

Schölmerich J.

Med Klin (Munich). 2010 Apr;105(4):219-24. doi: 10.1007/s00063-010-1050-6. German. No abstract available.

PMID:
20455036
48.

Innate immunity and adipose tissue biology.

Schäffler A, Schölmerich J.

Trends Immunol. 2010 Jun;31(6):228-35. doi: 10.1016/j.it.2010.03.001. Review.

PMID:
20434953
49.

Papillary thyroid cancer associated with syndrome of inappropriate antidiuresis: a case report.

Beier F, Moleda L, Guralnik V, Hahn P, Schardt K, Andreesen R, Schölmerich J, Schäffler A.

J Med Case Rep. 2010 Apr 21;4:110. doi: 10.1186/1752-1947-4-110.

50.

Emerging drugs to treat Crohn's disease.

Strauch U, Schölmerich J.

Expert Opin Emerg Drugs. 2010 Jun;15(2):309-22. doi: 10.1517/14728214.2010.480972. Review.

PMID:
20402560

Supplemental Content

Loading ...
Support Center